In another study aiming at identifying differentially expressed genes in blood samples of AD patients, it has been suggested that mitochondrial dysfunction, nuclear factor-κB (NF-κB) signaling and inducible Nitric Oxide Synthase (iNOS) signaling pathways are all dysregulated in AD pathophysiology [175]. This evidence concerns the gene NOS2 and Alzheimer disease.